Secor Capital Advisors’s AtriCure ATRC Stock Holding History

Secor Capital Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-18,031	Closed	-$552K	–	410
2018 Q4	$552K	Buy	18,031 +9,281	+106%	+$289K	0.07%	303
2018 Q3	$307K	Buy	+8,750	New	+$277K	0.03%	365
2016 Q3	–	Sell	-53,017	Closed	-$749K	–	509
2016 Q2	$749K	Buy	+53,017	New	+$808K	0.09%	294

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Secor Capital Advisors's ATRC Position: Q1 2019 in Review

Secor Capital Advisors sold out of AtriCure (ATRC) in Q1 2019, closing a stake of 18,031 shares — an estimated $552K sold.

Secor Capital Advisors first reported a position in ATRC in Q2 2016 and held it in 3 quarters. The position peaked at $749K in Q2 2016. 160 funds tracked by Wall St. Rank hold ATRC as of Q1 2019.

Secor Capital Advisors reported no remaining AtriCure position as of Q1 2019 after selling out during the quarter.
Secor Capital Advisors sold 18,031 AtriCure shares in Q1 2019, an estimated $552K.
Secor Capital Advisors first reported a position in AtriCure in Q2 2016 and held it in 3 quarters.
Secor Capital Advisors's AtriCure position peaked at $749K in Q2 2016.
160 funds tracked by Wall St. Rank held AtriCure as of Q1 2019.

Based on Secor Capital Advisors's 13F filing for Q1 2019, filed 15 May 2019.